Domestic Animal Endocrinology
Volume 39, Issue 3 , Pages 194-204 , October 2010

Basal measures of insulin sensitivity and insulin secretion and simplified glucose tolerance tests in dogs

References 

  1. Kauffman R, Castracane V. Assessing insulin sensitivity. Cont Ob/Gyn. 2003;48:30–48
  2. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19:527–534
  3. Finegood DT, Pacini G, Bergman RN. The insulin sensitivity index: Correlation in dogs between values determined from the intravenous glucose tolerance test and the euglycaemic glucose clamp. Diabetes. 1984;33:362–368
  4. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  5. Radziuk J. Insulin sensitivity and its measurement: Structural commonality among the methods. J Clin Endocrinol Metab. 2000;85:4426–4433
  6. Katz A, Nambi SS, Mather K, Baron A, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410
  7. Appleton DJ, Rand JS, PhD GDS. Basal plasma insulin and homeostasis model assessment (homa) are indicators of insulin sensitivity in cats. J Feline Med Surg. 2005;7:183–193
  8. Levy J, Morris R, Hammersley M, Turner R. Discrimination, adjusted correlation, and equivalence of imprecise tests: Application to glucose tolerance. Am J Physiol. 1999;276:E365–E375
  9. Wallace TM, Levy JC, Matthews DR. Use and abuse of homa modeling. Diabetes Care. 2004;27:1487–1495
  10. Toffolo G, Bergman RN, Finegood DT, Bowden CR, Cobelli C. Quantitative estimation of beta cell sensitivity to glucose in the intact organism: A minimal model of insulin kinetics in the dog. Diabetes. 1980;29:979–990
  11. Pacini G, Bergman RN. Minmod: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed. 1986;23:113–122
  12. Christopher MJ, Rantzau C, Ward GM, Alford FP. Insulinopenia and hyperglycemia influence the in vivo partitioning of ge and si. Am J Physiol. 1995;268:E410–E421
  13. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29:1130–1139
  14. Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R. Canine and feline diabetes mellitus: Nature or nurture?. J Nutr. 2004;134:2072S–2080S
  15. Backus RC. Advances in knowledge about feline metabolism. Compendium on Continuing Education for the Practicing Veterinarian. 2008;30:17–24
  16. Schianca GPC, Rossi A, Sainaghi PP, Maduli E, Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance (Importance of insulin secretion and resistance). Diabetes Care. 2003;26:1333–1337
  17. Porte D. Banting lecture 1990 (Beta-cells in type II diabetes mellitus). Diabetes. 1991;40:166–180
  18. Hoenig M. Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol. 2002;197:221–229
  19. Steil GM, Murray J, Bergman RN, Buchanan TA. Repeatability of insulin sensitivity and glucose effectiveness from the minimal model (Implications for study design). Diabetes. 1994;43:1365–1371
  20. Duysinx BC, Scheen AJ, Gerard PL, Letiexhe MR, Paquot N, Lefebvre PJ. Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test: Validity and reproducibility. Diabete et Metabolisme. 1994;20:425–432
  21. Verkest KR, Fleeman LM, Rand JS, Morton JM. Spontaneously obese dogs maintain beta-cell sensitivity to glucose and first-phase insulin secretion, unlike obese cats and human beings. Am J Vet Res. In press.
  22. Rottiers R, Mattheeuws D, Kaneko JJ, Vermeulen A. Glucose uptake and insulin secretory responses to intravenous glucose loads in the dog. Am J Vet Res. 1981;42:155–158
  23. LaFlamme D. Development and validation of a body condition score system for dogs. Canine Pract. 1997;22:10–15
  24. Laakso M. How good a marker is insulin level for insulin resistance?. Am J Epidemiol. 1993;137:959–965
  25. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83:2694–2698
  26. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (homa) evaluation uses the computer program. Diabetes Care. 1998;21:2191–2192
  27. Bland JM, Altman DG. Measurement error and correlation coefficients. Br Med J. 1996;313:41–42
  28. Bland JM, Altman DG. Measurement error proportional to the mean. Br Med J. 1996;313:106–106
  29. Lin L. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255–268
  30. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135–160
  31. Quon MJ. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab. 2001;86:4615–4617
  32. Bergman RN, Bucolo RJ. Interaction of insulin and glucose in the control of hepatic glucose balance. Am J Physiol. 1974;227:1314–1322
  33. Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: Estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 1979;28:1086–1096
  34. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Resistance EGftSoI (Insulin resistance and hypersecretion in obesity). J Clin Invest. 1997;100:1166–1173
  35. Hong J, Gui MH, Gu WQ, Zhang YF, Xu M, Chi ZN, et al. Differences in insulin resistance and pancreatic b-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose. Diabet Med. 2008;25:73–79
  36. Kim SP, Ellmerer M, Van Citters GW, Bergman RN. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes. 2003;52:2453–2460
  37. Lund EM, Armstrong PJ, Kirk CA, Klausner JS. Prevalence and risk factors for obesity in adult dogs from private us veterinary practices. Intern J Appl Res Vet Med. 2006;4:177–186
  38. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia. 1999;42:678–687
  39. Polonsky KS, Pugh W, Jaspan JB, Cohen DM, Karrison T, Tager HS, et al. C-peptide and insulin secretion (Relationship between peripheral concentrations of c-peptide and insulin and their secretion rates in the dog). J Clin Invest. 1984;74:1821–1829
  40. Kim SP, Ellmerer M, Kirkman EL, Bergman RN. Beta-cell “Rest” Accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model. Am J Physiol Endocrinol. 2007;292:E1581–E1589
  41. Mittelman SD, Van Citters GW, Kim SP, Davis DA, Dea MK, Hamilton Wessler M, et al. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes. 2000;49:2116–2125
  42. Harding PE, Bloom G, Field JB. Effect of infusion of insulin into portal vein on hepatic extraction of insulin in anesthetized dogs. Am J Physiol. 1975;228:1580–1588
  43. Morishima T, Bradshaw C, Radziuk J. Measurement using tracers of steady-state turnover and metabolic clearance of insulin in dogs. Am J Physiol Endocrinol Metab. 1985;248:E203–E208
  44. Turner RC, Grayburn JA, Newman GB, Nabarro JD. Measurement of the insulin delivery rate in man. J Clin Endocrinol Metab. 1971;33:279–286
  45. Matthews DR, Rudenski AS, Burnett MA, Darling P, Turner RC. The half-life of endogenous insulin and c-peptide in man assessed by somatostatin suppression. Clin Endocrinol (Oxf). 1985;23:71–79
  46. Sonksen PH, Tompkins CV, Srivastava MC, Nabarro JD. A comparative study on the metabolism of human insulin and porcine proinsulin in man. Clin Sci Mol Med. 1973;45:633–654
  47. Reichard GAJR, Jacobs AG, Kimbel P, Hochella NJ, Weinhouse S. Blood glucose replacement rates in normal and diabetic humans. J Appl Physiol. 1961;16:789–795
  48. Forbath N, Hetenyi GJ. Glucose dynamics in normal subjects and diabetic patients before and after a glucose load. Diabetes Metab. 1966;15:778–789
  49. Cherrington AD, Chiasson JL, Liljenquist JE, Jennings AS, Keller U, Lacy WW. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest. 1976;58:1407–1418
  50. Steele R, Bishop JS, Dunn A, Altszuler N, Rathgeb I, de Bodo RC. Inhibition by insulin of hepatic glucose production in the normal dog. Am J Physiol. 1965;208:301–306
  51. Ader M, Bergman RN. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol Endocrinol Metab. 1990;258:E1020–E1032
  52. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps (Comparison of unlabeled and labeled exogenous glucose infusates). Diabetes. 1987;36:914–924
  53. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes. 1998;47:523–529
  54. Searle GL, Strisower EH, Chaikoff IL. Glucose pool and glucose space in the normal and diabetic dog. Am J Physiol. 1954;176:190–194
  55. Rowe GG, Maxwell GM, Castillo CA, Freeman DJ, Crumpton CW. A study in man of cerebral blood flow and cerebral glucose, lactate and pyruvate metabolism before and after eating. J Clin Invest. 1959;38:2154–2158
  56. Betz AL, Gilboe DD, Yudilevich DL, Drewes LR. Kinetics of unidirectional glucose transport into the isolated dog brain. Am J Physiol. 1973;225:586–592
  57. Gilboe DD, Betz AL. Oxygen uptake in the isolated canine brain. Am J Physiol. 1973;224:588–595
  58. Gittleman JL. Carnivore brain size, behavioral ecology, and phylogeny. J Mammal. 1986;67:23–36
  59. Chudler EH. Brain facts and figures. February 12, 2009;University of Washington
  60. Van Dongen PAM. Brain size in vertebrates. In:  Nieuwenhuys Rea editors. The Central Nervous System of Vertebrates. Berlin: Springer Verlag; 1998;p. 2099–2134
  61. Betz AL, Gilboe DD, Yudilevich DL, Drewes LR. Kinetics of unidirectional glucose transport into the isolated dog brain. Am J Physiol. 1973;225:586–592
  62. Turner RC, Oakley NW, Nabarro JDN. Control of basal insulin secretion, with special reference to the diagnosis of insulinomas. Br Med J. 1971;2:132–135

 L. Fleeman is currently at Animal Diabetes Australia in Melbourne, Australia. J. Morton is currently the veterinary epidemiological consultant at Jemora Pty Ltd, Geelong, Victoria, Australia.

PII: S0739-7240(10)00062-7

doi: 10.1016/j.domaniend.2010.06.001

Domestic Animal Endocrinology
Volume 39, Issue 3 , Pages 194-204 , October 2010